查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990447

动脉瘤夹市场：2026-2032年全球市场预测（依手术技术、材料、夹子类型、应用、最终用户和分销管道划分）

Aneurysm Clips Market by Surgical Technique, Material, Clip Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年动脉瘤夹市场价值为 8,720 万美元，预计到 2026 年将成长至 9,207 万美元，复合年增长率为 6.46%，到 ​​2032 年将达到 1.3519 亿美元。

主要市场统计数据
基准年 2025 8720万美元
预计年份：2026年 9207万美元
预测年份：2032年 1.3519亿美元
复合年增长率 (%) 6.46%

对影响动脉瘤夹市场和器械采用的临床、技术和采购因素进行关键性介绍性说明。

动脉瘤夹闭术仍然是神经外科治疗方法中至关重要的环节，它融合了数十年的技术改进以及材料和手术流程的持续创新。随着临床医生在开放手术的优势与不断发展的微创技术之间寻求平衡，人们越来越关注那些能够最大限度地提高闭塞可靠性，同时最大限度减少对周围组织损伤和影像伪影的器械。影像学、神经导航和术中监测技术的同步进步，不仅提高了动脉瘤夹选择和放置的精确度，也提高了与数位化手术工作流程的兼容性要求。

对重塑动脉瘤夹产品开发和部署模式的关键技术、监管和商业性变化进行分析概述。

在技​​术融合和临床偏好不断演变的驱动下，动脉瘤夹闭器材正经历一系列变化。随着微创和影像导引介入治疗的日益普及，製造商正在重新思考夹子的形态、渗透性和人体工学设计，以实现更快、更可靠的定位。同时，诸如改良钛合金和聚合物复合材料等材料的创新正在减少影像伪影并提高生物相容性，从而改变围手术全期工作流程和术后影像策略。

重点评估 2025 年新的收费系统将如何影响所有相关人员。

2025年新关税措施的实施将进一步加剧医疗设备相关人员现有供应链的复杂性，因此亟需对筹资策略进行快速重新评估。进口关税的增加正在影响海外供应商零件和成品的供应，一些製造商正在考虑将生产转移到近岸地区或扩大国内产能，以此来控制总体成本并最大限度地降低未来政策变化带来的风险。同时，经销商和医院采购团队正在审查合约条款，以减轻利润率下降的影响并维持服务水准。

策略性细分洞察，解释了应用、手术技术、最终用户、分销、材料和夹子类型如何影响临床和商业性重点。

市场区隔为将宏观趋势转化为目标产品和商业策略提供了关键观点。当以应用领域（区分颅内和周边应用）分析市场时，设计重点也会随之改变。颅内应用需要极高的精准控制、低轮廓外形和影像相容性，而周边应用则更注重稳健性、多样化的尺寸选择以及基于血管解剖结构的可操作性。相较之下，依手术入路（涵盖血管内手术和开放手术）进行细分则会为器械的演进开闢不同的路径。血管内手术强调与导航系统和基于导管的辅助装置的兼容性，而开放性手术则对机械可靠性和触觉回馈有着严格的要求。

区域分析：重点分析美洲、欧洲、中东、非洲和亚太地区在监管、临床引入和商业性趋势方面的差异。

区域趋势正以不同的方式影响创新路径和商业性实施。在美洲，先进的神经外科中心和综合医疗保健系统优先考虑临床疗效、手术效率和器械的长期性能。这种环境有利于拥有强有力临床证据和完善服务模式的器械，而采购团队则要求提供供应链韧性和上市后安全性资料的相关文件。该地区的过渡性政策和支付模式也促进了围绕综合护理路径和器械定价结构的谈判。

对动脉瘤夹生态系中各公司的竞争策略、伙伴关係模式和创新重点进行评估性观点。

动脉瘤夹闭术领域的竞争动态由技术差异化、监管记录和商业性支持品质三者共同决定。主要企业正集中投资于材料科学、器械人体工学和实证医学证据的积累，以支持临床应用。同时，与手术中心和经销商建立伙伴关係，开展培训、病例观察和收集外科医生回馈，正成为加速产品推广、减少部署阻力的有效途径。

为经营团队提供切实可行的、优先考虑的建议，以协调创新、供应链韧性和商业策略，从而确保可持续的竞争优势。

寻求获得可持续竞争优势的产业领导者应采取整合策略，将技术创新、业务永续营运和与临床医生的合作相结合。首先，他们必须优先考虑供应链多元化，并透过投资本地製造和认证的契约製造伙伴关係关係来降低贸易中断的风险。同时，他们也应建立健全的库存和需求规划流程，以避免即使在政策或物流衝击的情况下也出现服务中断。其次，他们应将研发资源投入到能够显着减少影像伪影并支持长期生物相容性的材料和表面技术中，同时透过有针对性的临床合作来建立依证。

对支持研究结果的混合方法研究设计、主要和次要调查、三角测量检验以及局限性进行透明的解释。

本研究采用系统性的调查方法，将一手质性研究与严谨的二手资讯检验结合。一手资料包括对执业神经外科医师、血管专科医生、采购经理和供应链经理的半结构式访谈，旨在了解医疗设备的实际使用情况、选择因素和采购限制。这些一线观点揭示了医疗设备的性能标准和推广应用障碍，并被用于建构后续访谈中与供应商和分销商的访谈问题。

简洁的结论整合了临床、技术和商业性要求，并明确了相关人员为确保策略地位而应采取的优先行动。

综合以上观察，我们认为该领域正处于十字路口。临床技术的进步和影像主导的工作流程提高了人们对医疗设备效能的期望，而商业性和政策压力则要求供应链具备韧性，并提供兼顾成本效益的价值提案。材料创新、与临床医师进行深入合作以及积极与监管机构沟通，正逐渐成为确立产品领先地位的有效途径。同时，应对区域市场动态需要采取个人化的方法，尊重当地的管理体制、采购机制和临床能力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：动脉瘤夹市场：依手术方法划分

  • 血管内
  • 开放性手术

第九章：动脉瘤夹市场：依材料分类

  • 钴合金
  • 聚合物
  • 钛

第十章：动脉瘤夹市场：依夹子类型划分

  • 弧形字体
  • 窗户类型
  • 直型

第十一章 动脉瘤夹市场：依应用领域划分

  • 颅内
  • 外围

第十二章 动脉瘤夹市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专业医疗中心

第十三章 动脉瘤夹市场：依通路划分

  • 离线
  • 在线的

第十四章 动脉瘤夹市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 动脉瘤夹市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 动脉瘤夹市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国动脉瘤夹市场

第十八章：中国动脉瘤夹市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Adeor Medical AG
  • Aesculap AG
  • Aesculap Inc.
  • Aroa Biosurgery Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Cook Medical Incorporated
  • Edwards Lifesciences Corporation
  • G. Surkin & Co. Ltd.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • KLS Martin Group
  • Lemaitre Vascular Inc.
  • Medtronic plc
  • MicroVention Inc.
  • Natus Medical Incorporated
  • Peter Lazic GmbH
  • Stryker Corporation
  • Synovis Micro Companies Alliance Inc.
  • Teleflex Incorporated
  • Vycor Medical Inc.
  • WL Gore & Associates Inc.
  • Zeppelin Medical Devices
Product Code: MRR-3A68B83976BD

The Aneurysm Clips Market was valued at USD 87.20 million in 2025 and is projected to grow to USD 92.07 million in 2026, with a CAGR of 6.46%, reaching USD 135.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 87.20 million
Estimated Year [2026] USD 92.07 million
Forecast Year [2032] USD 135.19 million
CAGR (%) 6.46%

A focused introduction to clinical, technological, and procurement forces shaping the aneurysm clip landscape and influencing device uptake

Aneurysm clipping remains a critical component in the neurosurgical armamentarium, combining decades of technical refinement with ongoing material and procedural innovation. As clinicians balance the merits of open surgical approaches against evolving minimally invasive techniques, attention has turned to devices that maximize occlusion reliability while minimizing collateral tissue trauma and imaging artefacts. Parallel advancements in imaging, neuro-navigation, and intraoperative monitoring have increased the precision with which clips are selected and deployed, and have also raised the bar for device compatibility with digital surgical workflows.

In addition to clinical drivers, procurement and distribution dynamics now influence device selection from hospital systems to specialty centers. Manufacturers and suppliers must respond to heightened expectations for traceability, sterilization assurance, and supply continuity, while surgeons demand predictable handling characteristics and long-term biocompatibility. Consequently, product development has migrated beyond simple mechanical design to encompass material science, surface engineering, and integration with advanced surgical platforms. These changes have real implications for clinical training, procurement policy, and the design of post-market surveillance programs.

Given this evolving context, stakeholders need a concise synthesis of technological, regulatory, and commercial influences that shape decision-making across institutions. The following sections unpack these influences with an emphasis on actionable insight and sector-specific implications.

An analytical overview of the major technological, regulatory, and commercial shifts that are reshaping product development and adoption patterns in aneurysm clips

The aneurysm clip sector is experiencing a series of transformative shifts driven by technological convergence and shifting clinical preferences. Minimally invasive and image-guided interventions have grown in capability and acceptance, prompting manufacturers to re-evaluate clip geometry, radiopacity, and instrument ergonomics to support faster, more reliable deployment. At the same time, material innovations, including refined titanium alloys and polymer composites, are reducing imaging artefacts and improving biocompatibility, which in turn alters perioperative workflows and follow-up imaging strategies.

Moreover, the integration of digital systems into the operating room-from intraoperative angiography to navigation platforms-has elevated the importance of device interoperability. Regulatory frameworks have simultaneously evolved to place greater emphasis on post-market surveillance, device traceability, and clinician-reported outcomes, which shifts R&D priorities toward evidence generation and lifecycle management. Commercially, procurement channels are fragmenting as non-traditional buying models and online procurement portals gain traction alongside long-established distributor networks and direct hospital buying arrangements.

Consequently, suppliers must balance innovation with operational resilience: product differentiation through materials and design must be matched by investments in manufacturing quality, supply chain transparency, and clinical education to ensure adoption. These shifts create both opportunity and risk, making strategic clarity essential for those looking to sustain competitive advantage.

A focused assessment of how new tariff dynamics in 2025 are influencing sourcing choices, supply chain resilience, and commercial risk management across stakeholders

The introduction of new tariff measures in 2025 has compounded existing supply chain complexities for medical device stakeholders, necessitating rapid reassessment of sourcing strategies. Increased import duties affect component flows and finished goods originating from international suppliers, prompting some manufacturers to consider nearshoring or expanding domestic production capabilities as a way to control landed costs and minimize exposure to future policy shifts. At the same time, distributors and hospital procurement teams are reassessing contractual terms to mitigate margin compression and maintain service levels.

Operationally, tariffs influence inventory management and contract cadence: organizations are inclined to increase safety stock or renegotiate lead times to reduce exposure to price volatility, which has knock-on effects for working capital and storage logistics. From a competitive perspective, firms with diversified manufacturing footprints or integrated supply chains enjoy greater flexibility to absorb or offset tariff-driven cost increases without immediate price pass-through to end users. Conversely, smaller suppliers that rely heavily on imported components face acute pressure to preserve margin and may pursue strategic partnerships or consolidation to preserve market access.

Importantly, clinical institutions and purchasing groups have limited appetite for abrupt price increases, which increases scrutiny on value-added services such as clinical education, warranty provisions, and device performance guarantees. Accordingly, stakeholders should evaluate supplier resilience, contract structures, and regional production options as they navigate the evolving tariff environment and its cumulative operational impacts.

Strategic segmentation insights that explain how application, surgical technique, end user, distribution, material, and clip type shape clinical and commercial priorities

Segmentation provides a necessary lens for translating overarching trends into targeted product and commercial strategies. When the market is examined by application-distinguishing between intracranial and peripheral use cases-design priorities change: intracranial applications demand exquisite control, low-profile geometries, and imaging compatibility, while peripheral applications prioritize robustness, different sizing options, and handling characteristics tailored to vascular anatomy. In contrast, surgical technique segmentation-covering endovascular and open approaches-creates divergent pathways for device evolution, where endovascular procedures emphasize compatibility with navigation systems and catheter-based adjuncts, and open techniques retain strong requirements for mechanical reliability and tactile feedback.

End-user segmentation further refines commercialization priorities; ambulatory surgical centers, hospitals, and specialty centers each present different buying cycles, bundling requirements, and post-operative follow-up practices that influence how products are positioned and supported. Distribution channel segmentation-spanning direct sales, distributors, and online sales-affects margin structures, service expectations, and speed of deployment; direct engagement supports bespoke training and procurement integration, distributors offer breadth and regional reach, and online channels accelerate access for standardized products. Material segmentation across cobalt alloy, polymer, and titanium reveals trade-offs between strength, imaging behaviour, and biocompatibility that intersect with regulatory pathways and long-term surveillance needs. Finally, clip type segmentation-curved, fenestrated, and straight-dictates instrument compatibility, surgeon preference patterns, and inventory rationalization strategies. Together, these segmentation axes deliver a layered framework that informs product design, clinical evidence generation, and tailored commercial models.

Regional analysis highlighting distinct regulatory, clinical adoption, and commercial dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape both innovation pathways and commercial execution in distinct ways. In the Americas, advanced neurosurgical centers and integrated health systems prioritize clinical outcomes, procedural efficiency, and longitudinal device performance. This environment favors devices with strong clinical evidence and comprehensive service models, while procurement teams demand documentation of supply chain resilience and post-market safety data. Transitional policies and payer models in the region also drive negotiation over bundled care pathways and device pricing structures.

In Europe, Middle East & Africa, regulatory harmonization in some jurisdictions coexists with highly localized procurement processes, creating a mosaic of requirements for device approvals and commercialization. Reimbursement models vary significantly, and in several markets there is a premium placed on products that reduce procedure time or enable faster discharge. The diversity of infrastructure across the region means that distributors and local partners play a critical role in education, training, and installation support.

Meanwhile, Asia-Pacific presents a blend of high-volume clinical demand and rapidly maturing manufacturing capabilities. Several markets within the region are emphasizing domestic production and regulatory acceleration for innovative devices, which can create both competitive pressure and partnership opportunities. Adoption in the region is influenced by capacity expansion in tertiary centers, price sensitivity in public systems, and an increasing emphasis on evidence generation to support broader uptake. Collectively, these regional distinctions necessitate tailored market entry strategies and localized value propositions.

An evaluative perspective on competitive strategies, partnership models, and innovation priorities among companies operating in the aneurysm clip ecosystem

Competitive dynamics in the aneurysm clip sector are shaped by a combination of technical differentiation, regulatory track records, and the quality of commercial support. Leading players focus investment on materials science, device ergonomics, and evidence generation to support clinical adoption. At the same time, partnerships with surgical centers and distributors for training, case observation, and surgeon feedback have emerged as an effective route to accelerate adoption while reducing implementation friction.

Strategic activity also includes targeted acquisitions and co-development agreements to fill gaps in capabilities-whether that be in advanced alloy processing, polymer technology, or digital integration that enhances intraoperative decision-making. Firms that demonstrate consistent regulatory compliance and robust post-market surveillance tend to build stronger trust with hospital procurement teams and physician groups. In addition, companies that successfully align product portfolios with service offerings, such as simulation-based training and clinical data services, strengthen customer relationships and create differentiated value beyond the device itself.

Smaller and mid-sized innovators often concentrate on niche differentiation-such as unique clip geometries or material blends-while leveraging distribution partnerships to scale. For stakeholders evaluating competitive positioning, the key considerations are how material and design choices translate to clinical benefit, how regulatory and quality systems are structured, and how commercial models address the practical needs of diverse end users.

Practical and prioritized recommendations for executive teams to align innovation, supply resilience, and commercial strategies for sustained competitive advantage

Industry leaders seeking to secure durable advantage should pursue integrated strategies that align technical innovation with operational resilience and clinician engagement. First, prioritize diversification of the supply base and invest in regional manufacturing or qualified contract manufacturing relationships to reduce exposure to trade disruptions. This should be coupled with robust inventory and demand planning processes to avoid service interruptions during policy or logistical shocks. Second, allocate R&D resources to materials and surface technologies that demonstrably reduce imaging artefacts and support long-term biocompatibility, while concurrently building an evidence base through targeted clinical collaborations.

Third, strengthen post-market surveillance and clinician feedback loops to accelerate iterative product improvements and to reassure procurement stakeholders of safety and performance. Fourth, tailor commercial models to end-user segments: offer bundled services and training for hospitals and specialty centers, while optimizing standardized SKU availability and digital ordering pathways for ambulatory surgical centers. Fifth, pursue regulatory strategy proactively by aligning submissions with the most stringent jurisdictions relevant to your customer base, thereby easing entry into adjacent markets. Finally, develop clear value narratives that quantify operational benefits such as reduced procedure time, improved imaging follow-up, and lower reoperation rates, and present these narratives through clinician-led case studies and payer-oriented dossiers. These steps will collectively strengthen positioning and reduce execution risk.

A transparent description of the mixed-method research design, primary and secondary inputs, triangulation procedures, and limitations that underpin the findings

This research synthesis is grounded in a structured methodological approach that combines primary qualitative engagement with rigorous secondary source validation. Primary inputs included semi-structured interviews with practicing neurosurgeons, vascular specialists, procurement leaders, and supply chain managers to capture real-world device usage, preference drivers, and procurement constraints. These firsthand perspectives informed device performance criteria and adoption barriers, and they were used to shape follow-up questions for supplier and distributor interviews.

Secondary research involved systematic review of peer-reviewed clinical literature, regulatory agency communications, device registries, and publicly available technical documentation to validate technical claims, material performance insights, and post-market trends. Triangulation was applied across primary and secondary inputs to ensure consistency and to identify divergence that warranted deeper investigation. Analytical techniques incorporated comparative device attribute mapping, scenario analysis around supply disruption and tariff impacts, and segmentation crosswalks to align product features with end-user needs. Quality assurance processes included expert peer review, methodological transparency, and sensitivity checks to highlight areas of higher uncertainty. Limitations include potential variability in regional regulatory interpretation and institution-specific purchasing policies, which the report addresses by providing contextualized scenarios rather than universal prescriptions.

A concise conclusion that synthesizes clinical, technical, and commercial imperatives and clarifies priority actions for stakeholders to secure strategic positioning

The cumulative observations point to a sector at a crossroads: clinical advancements and imaging-driven workflows are raising expectations for device performance, while commercial and policy pressures demand supply chain resilience and cost-aware value propositions. Material innovation, informed clinician collaboration, and proactive regulatory engagement emerge as consistent levers for successful product leadership. At the same time, geographic market dynamics require tailored approaches that respect local regulatory regimes, procurement mechanisms, and clinical capacity.

Taken together, these insights suggest that success will favor organizations that combine differentiated device attributes with robust operational capabilities and sustained clinician partnerships. Investment in evidence generation and in systems that reduce exposure to supply disruption will be especially important in the current environment. For stakeholders across the value chain, the imperative is clear: align product development with the pragmatic realities of hospital and specialty center operations, and translate clinical benefits into tangible operational and patient-care improvements. Doing so will facilitate adoption and reduce commercial friction, positioning organizations to capture strategic opportunities as the clinical and policy landscape continues to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aneurysm Clips Market, by Surgical Technique

  • 8.1. Endovascular
  • 8.2. Open

9. Aneurysm Clips Market, by Material

  • 9.1. Cobalt Alloy
  • 9.2. Polymer
  • 9.3. Titanium

10. Aneurysm Clips Market, by Clip Type

  • 10.1. Curved
  • 10.2. Fenestrated
  • 10.3. Straight

11. Aneurysm Clips Market, by Application

  • 11.1. Intracranial
  • 11.2. Peripheral

12. Aneurysm Clips Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Centers

13. Aneurysm Clips Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Aneurysm Clips Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Aneurysm Clips Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Aneurysm Clips Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Aneurysm Clips Market

18. China Aneurysm Clips Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Adeor Medical AG
  • 19.6. Aesculap AG
  • 19.7. Aesculap Inc.
  • 19.8. Aroa Biosurgery Limited
  • 19.9. B. Braun Melsungen AG
  • 19.10. Baxter International Inc.
  • 19.11. Boston Scientific Corporation
  • 19.12. Cook Medical Incorporated
  • 19.13. Edwards Lifesciences Corporation
  • 19.14. G. Surkin & Co. Ltd.
  • 19.15. Integra LifeSciences Holdings Corporation
  • 19.16. Johnson & Johnson
  • 19.17. KLS Martin Group
  • 19.18. Lemaitre Vascular Inc.
  • 19.19. Medtronic plc
  • 19.20. MicroVention Inc.
  • 19.21. Natus Medical Incorporated
  • 19.22. Peter Lazic GmbH
  • 19.23. Stryker Corporation
  • 19.24. Synovis Micro Companies Alliance Inc.
  • 19.25. Teleflex Incorporated
  • 19.26. Vycor Medical Inc.
  • 19.27. W. L. Gore & Associates Inc.
  • 19.28. Zeppelin Medical Devices

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANEURYSM CLIPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANEURYSM CLIPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ENDOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ENDOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COBALT ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COBALT ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COBALT ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CURVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CURVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CURVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY FENESTRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY FENESTRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY FENESTRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY STRAIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY STRAIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY STRAIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. GCC ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. GCC ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. G7 ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NATO ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)